See "Specific therapies in CLL: mechanisms of resistance and approaches for administration" on site 471.Current molecular reports have furnished a lot of insights into the processes that govern the event and development of CLL, which includes lots of novel mutated genes clustered in numerous useful pathways. The CLL epigenome is reprogrammed in the